肺癌中的立体体射线疗法:当代审查
Emese Csiki1,2, Mihály Simon1, Judit Papp1
1Department of Oncoradiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Pathology oncology research : POR
|March 13, 2024
概括
立体性身体放射疗法 (SBRT) 为早期非小细胞肺癌 (NSCLC) 提供了高度的局部控制. 这项研究回顾了SBRT的进展,表明它在可手术的患者中作为手术替代品的潜在用途.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 胸部外科手术 胸部外科手术
背景情况:
- 叶切除术仍然是可操作的早期非小细胞肺癌 (NSCLC) 的标准.
- 立体性身体辐射疗法 (SBRT) 提供了高的局部控制和生存率的不可操作的NSCLC.
- 在SBRT规划和交付方面的进步改善了结果并降低了毒性.
研究的目的:
- 审查目前的发展,随机试验和肺SBRT的指导方针.
- 强调SBRT在改善适合性和可手术的NSCLC患者的局部控制和生存方面的潜力.
- 评估SBRT作为符合条件的患者手术的潜在替代方案.
主要方法:
- 最近随机研究的文献综述和临床指导方针.
- 分析SBRT规划和交付方面的技术进步.
- 专注于有关局部控制和整体生存的结果数据.
主要成果:
- 在治疗早期NSCLC方面,SBRT表现出高疗效.
- 改进的规划和交付技术提高了目标覆盖率,并最大限度地减少了副作用.
- 新出现的证据支持SBRT在可手术患者群体中的有效性.
结论:
- 对于早期NSCLC来说,SBRT是一种非常有效的治疗方法,特别是对于不可手术的病例.
- 持续的研究和技术改进正在扩大SBRT的作用.
- 在某些可操作的NSCLC患者中,SBRT可能成为手术的可行替代方案.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K